Bristol-Myers Squibb CompanyBristol-Myers Squibb CompanyBristol-Myers Squibb Company

Bristol-Myers Squibb Company

トレードなし
トレードなし

社債

以下は、Bristol-Myers Squibb Companyの社債をワースト利回り順に並べたリストです。投資家は、市場の変動が激しい時期において、比較的安定した投資先として社債を選ぶ傾向にあります。価格、利回り、その他の指標を分析して、信頼できる投資先を見つけましょう。
シンボル
YTW %
価格 %
クーポン %
満期日
発行残高
額面金額
S&P格付け
フィッチ格付け
ムーディーズ格付け
発行体
BBMY4597874Celgene Corporation 4.55% 20-FEB-2048
7.12%71.92%4.550%2048-02-2037.2 M USD1,000.00 USD
A
——
Celgene Corp.
BMY.GCBristol-Myers Squibb Company 6.875% 01-AUG-2097
6.80%101.02%6.875%2097-08-0156.24 M USD1,000.00 USD
A
—
A2
Bristol Myers Squibb Co.
BBMY4036425Celgene Corporation 5.25% 15-AUG-2043
6.53%87.00%5.250%2043-08-154.06 M USD1,000.00 USD
A
——
Celgene Corp.
BMY5009254Bristol-Myers Squibb Company 4.25% 26-OCT-2049
6.52%73.08%4.250%2049-10-263.75 B USD1,000.00 USD
A
—
A2
Bristol Myers Squibb Co.
BMY5009250Bristol-Myers Squibb Company 4.55% 20-FEB-2048
6.48%77.81%4.550%2048-02-201.24 B USD1,000.00 USD
A
—
A2
Bristol Myers Squibb Co.
US110122DX3Bristol-Myers Squibb Company 3.9% 15-MAR-2062
6.48%64.23%3.900%2062-03-151 B USD1,000.00 USD
A
—
A2
Bristol Myers Squibb Co.
US110122EC8Bristol-Myers Squibb Company 6.4% 15-NOV-2063
6.47%98.83%6.400%2063-11-15370.78 M USD1,000.00 USD
A
—
A2
Bristol Myers Squibb Co.
US110122EK0Bristol-Myers Squibb Company 5.55% 22-FEB-2054
6.46%88.37%5.550%2054-02-222.75 B USD1,000.00 USD
A
—
A2
Bristol Myers Squibb Co.
BMY5009251Bristol-Myers Squibb Company 4.35% 15-NOV-2047
6.46%75.86%4.350%2047-11-151.24 B USD1,000.00 USD
A
—
A2
Bristol Myers Squibb Co.
US110122EB0Bristol-Myers Squibb Company 6.25% 15-NOV-2053
6.45%97.28%6.250%2053-11-15438.54 M USD1,000.00 USD
A
—
A2
Bristol Myers Squibb Co.
US110122EL8Bristol-Myers Squibb Company 5.65% 22-FEB-2064
6.44%88.68%5.650%2064-02-22440.23 M USD1,000.00 USD
A
—
A2
Bristol Myers Squibb Co.
US110122DW5Bristol-Myers Squibb Company 3.7% 15-MAR-2052
6.44%65.84%3.700%2052-03-152 B USD1,000.00 USD
A
—
A2
Bristol Myers Squibb Co.
US110122DS4Bristol-Myers Squibb Company 2.55% 13-NOV-2050
6.42%52.76%2.550%2050-11-131.5 B USD1,000.00 USD
A
—
A2
Bristol Myers Squibb Co.
BMY5007349Bristol-Myers Squibb Company 5.25% 15-AUG-2043
6.41%88.10%5.250%2043-08-15218.37 M USD1,000.00 USD
A
—
A2
Bristol Myers Squibb Co.
BMY5009253Bristol-Myers Squibb Company 4.625% 15-MAY-2044
6.41%81.31%4.625%2044-05-15744.72 M USD1,000.00 USD
A
—
A2
Bristol Myers Squibb Co.
BRMGBristol-Myers Squibb Company 4.5% 01-MAR-2044
6.40%80.13%4.500%2044-03-01341.52 M USD1,000.00 USD
A
—
A2
Bristol Myers Squibb Co.
BMY5009252Bristol-Myers Squibb Company 5.0% 15-AUG-2045
6.32%85.51%5.000%2045-08-15741.72 M USD1,000.00 USD
A
—
A2
Bristol Myers Squibb Co.
US110122EJ3Bristol-Myers Squibb Company 5.5% 22-FEB-2044
6.30%91.55%5.500%2044-02-22500 M USD1,000.00 USD
A
—
A2
Bristol Myers Squibb Co.
US110122DV7Bristol-Myers Squibb Company 3.55% 15-MAR-2042
6.29%73.06%3.550%2042-03-151.25 B USD1,000.00 USD
A
—
A2
Bristol Myers Squibb Co.
BRMDBristol-Myers Squibb Company 3.25% 01-AUG-2042
6.28%69.75%3.250%2042-08-01500 M USD1,000.00 USD
A
—
A2
Bristol Myers Squibb Co.
BMY.GNBristol-Myers Squibb Company 6.125% 01-MAY-2038
6.13%99.92%6.125%2038-05-01219.25 M USD1,000.00 USD
A
—
A2
Bristol Myers Squibb Co.
BMY5007343Bristol-Myers Squibb Company 4.125% 15-JUN-2039
6.13%82.82%4.125%2039-06-152 B USD1,000.00 USD
A
—
A2
Bristol Myers Squibb Co.
US110122DR6Bristol-Myers Squibb Company 2.35% 13-NOV-2040
6.10%64.74%2.350%2040-11-13750 M USD1,000.00 USD
A
—
A2
Bristol Myers Squibb Co.
BBMY4560450Celgene Corporation 3.45% 15-NOV-2027
5.88%97.37%3.450%2027-11-1516.55 M USD1,000.00 USD
A
——
Celgene Corp.
BMY5007348Bristol-Myers Squibb Company 5.7% 15-OCT-2040
5.88%98.23%5.700%2040-10-15151.01 M USD1,000.00 USD
A
—
A2
Bristol Myers Squibb Co.
BMY.GLBristol-Myers Squibb Company 5.875% 15-NOV-2036
5.81%99.90%5.875%2036-11-15279.22 M USD1,000.00 USD
A
—
A2
Bristol Myers Squibb Co.
US110122EH7Bristol-Myers Squibb Company 5.2% 22-FEB-2034
5.73%96.78%5.200%2034-02-222.5 B USD1,000.00 USD
A
—
A2
Bristol Myers Squibb Co.
US110122DZ8Bristol-Myers Squibb Company 5.9% 15-NOV-2033
5.70%101.02%5.900%2033-11-15750 M USD1,000.00 USD
A
—
A2
Bristol Myers Squibb Co.
UUS151020BB94Celgene Corporation 3.9% 20-FEB-2028
5.53%97.85%3.900%2028-02-2043.84 M USD1,000.00 USD
A
——
Celgene Corp.
US110122DU9Bristol-Myers Squibb Company 2.95% 15-MAR-2032
5.51%88.04%2.950%2032-03-151.75 B USD1,000.00 USD
A
—
A2
Bristol Myers Squibb Co.
BMY5077468Bristol-Myers Squibb Company 1.45% 13-NOV-2030
5.47%85.50%1.450%2030-11-131.25 B USD1,000.00 USD
A
—
A2
Bristol Myers Squibb Co.
US110122EG9Bristol-Myers Squibb Company 5.1% 22-FEB-2031
5.41%98.75%5.100%2031-02-221.25 B USD1,000.00 USD
A
—
A2
Bristol Myers Squibb Co.
US110122DY1Bristol-Myers Squibb Company 5.75% 01-FEB-2031
5.41%101.20%5.750%2031-02-011 B USD1,000.00 USD
A
—
A2
Bristol Myers Squibb Co.
BMY5007342Bristol-Myers Squibb Company 3.4% 26-JUL-2029
5.29%95.11%3.400%2029-07-261.41 B USD1,000.00 USD
A
—
A2
Bristol Myers Squibb Co.
AA4EKWXBMS Ireland Capital Funding DAC 4.581% 10-NOV-20555.15%91.41%4.581%2055-11-101.2 B EUR1,000.00 EUR
A
——
BMS Ireland Capital Funding DAC
US110122EF1Bristol-Myers Squibb Company 4.9% 22-FEB-2029
5.10%99.55%4.900%2029-02-22726.69 M USD1,000.00 USD
A
—
A2
Bristol Myers Squibb Co.
AA4EKWWBMS Ireland Capital Funding DAC 4.289% 10-NOV-20454.91%92.35%4.289%2045-11-10750 M EUR1,000.00 EUR
A
——
BMS Ireland Capital Funding DAC
BMY5007347Bristol-Myers Squibb Company 3.9% 20-FEB-2028
4.91%98.66%3.900%2028-02-20497.17 M USD1,000.00 USD
A
—
A2
Bristol Myers Squibb Co.
BMY5007346Bristol-Myers Squibb Company 3.45% 15-NOV-2027
4.82%98.54%3.450%2027-11-15517.67 M USD1,000.00 USD
A
—
A2
Bristol Myers Squibb Co.
US110122DP0Bristol-Myers Squibb Company 1.125% 13-NOV-2027
4.69%96.21%1.125%2027-11-131 B USD1,000.00 USD
A
—
A2
Bristol Myers Squibb Co.
AA4EKWVBMS Ireland Capital Funding DAC 3.857% 10-NOV-20384.49%94.17%3.857%2038-11-101.15 B EUR1,000.00 EUR
A
——
BMS Ireland Capital Funding DAC
BRMJBristol-Myers Squibb Company 3.25% 27-FEB-2027
4.42%99.54%3.250%2027-02-27512.28 M USD1,000.00 USD
A
—
A2
Bristol Myers Squibb Co.
XS122674851Bristol-Myers Squibb Company 1.75% 15-MAY-2035
4.27%82.12%1.750%2035-05-15575 M EUR1,000.00 EUR
A
—
A2
Bristol Myers Squibb Co.
BMY.GBBristol-Myers Squibb Company 6.8% 15-NOV-2026
4.25%100.29%6.800%2026-11-15255.95 M USD1,000.00 USD
A
—
A2
Bristol Myers Squibb Co.
AA4EKWUBMS Ireland Capital Funding DAC 3.363% 10-NOV-20334.18%95.02%3.363%2033-11-101.15 B EUR1,000.00 EUR
A
——
BMS Ireland Capital Funding DAC
AA4EKWTBMS Ireland Capital Funding DAC 2.973% 10-NOV-20303.88%96.63%2.973%2030-11-10750 M EUR1,000.00 EUR
A
——
BMS Ireland Capital Funding DAC